Galera Therapeutics Announces Publication of GC4419 Data in the Journal of Clinical Oncology
December 05, 2019 17:18 ET
|
Galera Therapeutics
MALVERN, Pa., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel,...
Galera Therapeutics Announces Pricing of Initial Public Offering
November 06, 2019 19:26 ET
|
Galera Therapeutics
MALVERN, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel,...